(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 33.60%-9.58K | -4.96%-12.26K | 22.59%-156.8K | 92.15%-12.02K | -324.97%-118.67K | 12.37%-14.43K | -127.56%-11.69K | -1,627.73%-202.56K | -12,150.00%-153.04K | -27.92K |
Net income from continuing operations | -5.58%-54.75K | -7.99%-44.74K | 50.94%-219.65K | 30.85%-85.02K | 52.09%-41.35K | 74.24%-51.86K | -11.44%-41.42K | -1,732.21%-447.74K | -2,243.07%-122.94K | ---86.3K |
Remuneration paid in stock | --6.13K | --4.49K | -29.28%26.77K | ---- | ---- | --0 | --0 | --37.85K | ---- | ---- |
Other non cashItems | --1.8K | --1.8K | -98.52%2.4K | ---- | ---- | ---- | ---- | 1,346.15%162K | --0 | --12K |
Change In working capital | -0.50%37.24K | -11.95%26.19K | -25.69%33.68K | 164.51%43.83K | -266.71%-77.32K | 7.39%37.43K | -7.18%29.74K | -10.59%45.33K | -1,142.58%-67.95K | --46.38K |
-Change in receivables | 369.65%3.38K | -126.86%-692 | 35.56%-1.95K | 72.07%-846 | ---2.43K | ---1.25K | --2.58K | ---3.03K | ---3.03K | --0 |
-Change in payables and accrued expense | -12.45%33.87K | -1.05%26.88K | -26.31%35.63K | 168.83%44.68K | -275.53%-74.89K | 15.24%38.68K | -26.66%27.16K | 71.96%48.35K | ---64.92K | --42.67K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 33.60%-9.58K | -4.96%-12.26K | 22.59%-156.8K | 92.15%-12.02K | -324.97%-118.67K | 12.37%-14.43K | -127.56%-11.69K | -1,627.73%-202.56K | -12,150.00%-153.04K | ---27.92K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -109.97%-73.3K | 0 | 16.39%-34.91K | 0 | -28.47K | |||||
Net PPE purchase and sale | ---- | ---- | -109.97%-73.3K | ---- | ---- | ---- | ---- | ---34.91K | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---28.47K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | -109.97%-73.3K | --0 | ---- | ---- | ---- | 16.39%-34.91K | --0 | ---28.47K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -79.11%60K | 0 | 287.23K | 0 | 0 | |||||
Net issuance payments of debt | ---- | ---- | --60K | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --250K | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --37.23K | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | -79.11%60K | --0 | ---- | ---- | ---- | --287.23K | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -86.15%27.45K | -81.07%39.71K | 31.09%209.81K | -85.74%51.73K | -56.18%183.7K | 27.89%198.13K | 31.09%209.81K | -15.11%160.05K | 126.69%362.85K | --419.24K |
Current changes in cash | 33.60%-9.58K | -4.96%-12.26K | -441.84%-170.1K | 92.15%-12.02K | -134.03%-131.97K | -105.46%-14.43K | -127.56%-11.69K | 274.64%49.76K | -1,020,133.33%-153.04K | ---56.39K |
End cash Position | -90.28%17.86K | -86.15%27.45K | -81.07%39.71K | -81.07%39.71K | -85.74%51.73K | -56.18%183.7K | 27.89%198.13K | 31.09%209.81K | 31.09%209.81K | --362.85K |
Free cash from | 33.60%-9.58K | -4.96%-12.26K | 3.10%-230.1K | 54.61%-85.32K | -324.97%-118.67K | 12.37%-14.43K | -127.56%-11.69K | -1,891.02%-237.47K | -14,898.74%-187.94K | ---27.92K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data